Yu, F. (2003). Experimental and Theoretical Studies on Molecular Geometry and Polymorphism in Crystalline Drug Substances. Masters thesis, Aston University.
Abstract
The phenomena of polymorphism and pseudo-polymorphism are introduced, together with their pharmaceutical importance. Some basic knowledge about rystallization is introduced as well as the methods of experimental structure determination. Theinformation about H-bonds and prediction of polymorphic forms is also given in the first chapter. The pharmaceutical role of Temozolomide and 5,5 diphenylhydantoin is introduced in the second chapter.Using aqueous acetic acid as solvent, we crystallized a hydrate of Temozolomide, and the same hydrate also grows in the water: acetone 1:1 mixed solvent. This hydrate has a space group of P21/m in a cell of dimensions a = 7.5158(9), b = 6.3044(13), c =9.5324(16) Å, β = 92.907(12), V = 451.09(13) Å3, Z)= 2. Its crystal structure wasdetermined by direct methods and refined by full-matrix least squares...
Publication DOI: | https://doi.org/10.48780/publications.aston.ac.uk.00021799 |
---|---|
Divisions: | College of Health & Life Sciences |
Additional Information: | Copyright © F. Yu, 2003. F. Yu asserts their moral right to be identified as the author of this thesis. This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without appropriate permission or acknowledgement. If you have discovered material in Aston Publications Explorer which is unlawful e.g. breaches copyright, (either yours or that of a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, libel, then please read our Takedown Policy and contact the service immediately. |
Institution: | Aston University |
Uncontrolled Keywords: | Molecular geometry and polymorphism,cystalline drug substance |
Last Modified: | 14 May 2025 09:05 |
Date Deposited: | 19 Mar 2014 17:40 |
Completed Date: | 2003-07 |
Authors: |
Yu, F.
|